BCAX Price Target Alert: $14.00. Issued by Goldman Sachs
Source: KlickAnalytics
2026-02-11 17:04:12 ET
Full story available on KlickAnalytics.com
Bicara Therapeutics Inc.
NASDAQ: BCAX
BCAX Trading
1.63% G/L:
$19.93 Last:
340,432 Volume:
$19.75 Open:
BCAX Latest News
March 04, 2026 08:30:00 am
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
February 26, 2026 04:01:00 pm
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
February 24, 2026 11:13:06 pm
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
February 24, 2026 04:01:00 pm
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
BCAX Stock Data
$817,548,781
24,302,552
0.5%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
